All News

2020

March

Media Release / Mar 23, 2020

Sandoz acquires US distribution rights to two key hospital injectable medicines, reinforcing strategic focus on key growth segment

Read More
Media Release / Mar 20, 2020

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

Read More
Media Release / Mar 02, 2020

Sandoz Resolves Generic Drug Antitrust Investigation in the U.S.

Read More

February

Media Release / Feb 06, 2020

AAM names Carol Lynch, Vice Chair of the Board

Read More
2019

November

Media Release / Nov 05, 2019

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo™ (pegfilgrastim-bmez)

Read More
Media Release / Nov 04, 2019

Sandoz lowers Glatopa® (glatiramer acetate injection) price in US to offer people with MS high-quality care at a more affordable price

Read More

October

Media Release / Oct 15, 2019

Sandoz and Pear Therapeutics announce Pear will solely commercialize reSET® and reSET-O®

Read More

September

Media Release / Sep 23, 2019

Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product

Read More
Media Release / Sep 05, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More

August

Media Release / Aug 29, 2019

Sandoz Inc. voluntarily recalls Losartan Potassium and Ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements

Read More